Our Work

Our lab uses genomics, microbiology, and computational biology to apply bioinformatic and epidemiological methods to interpret complex pathogen data and create a better understanding of infectious diseases.

MRSA

The Guthrie lab aims to investigate the genomic changes of MRSA throughout time to interpret the complexity of this ever-changing pathogen. By investigating epidemiological trends of MRSA using genomics, bioinformatics, and microbiology, this lab focuses on the patterns of MRSA transmission, the prediction of antimicrobial resistance, and the evolution of prevalent Canadian strains.  

 

Mycobacteria

The Guthrie lab uses whole genome sequencing (WGS) to support the investigation of tuberculosis (TB) outbreaks and improve our understanding of transmission risk factors. As part of the Comprehensive Resistance Prediction for Tuberculosis: an International Consortium (CRyPTIC) the Guthrie lab is contributing to improved genetic prediction of resistance and understanding the underlying mechanisms of resistance. In addition to TB research we are also investigating nontuberculous mycobacteria infection and antimicrobial resistance using WGS and bioinformatics.

 COVID-19

 

The Guthrie lab aims to further our understanding of the COVID-19 pandemic through genomic sequencing of SARS-CoV-2. Whole genome sequencing provides insight to risk factors for transmission and outbreaks.